+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

High-flow Nasal Cannula Market by Component, Indication, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532778
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The High-flow Nasal Cannula Market grew from USD 3.11 billion in 2023 to USD 3.38 billion in 2024. It is expected to continue growing at a CAGR of 9.17%, reaching USD 5.76 billion by 2030.

High-flow nasal cannula (HFNC) therapy is a non-invasive respiratory support system that delivers humidified and heated oxygen at high flow rates through a nasal cannula. HFNC is particularly essential in treating patients with acute respiratory failure or chronic obstructive pulmonary disease (COPD), as well as in pediatric care settings. Its primary application extends across various healthcare facilities, including intensive care units (ICUs), emergency departments, and home healthcare environments. As global healthcare systems continue to experience pressures such as rising patient numbers and varying levels of respiratory distress cases, the demand for HFNC devices has been increasing. Key growth factors influencing this market include technological advancements, increased awareness and adoption rates among healthcare professionals, and the growing geriatric population prone to respiratory disorders. The latest potential opportunities in this market lie in emerging economies where healthcare infrastructure is improving and awareness campaigns can boost adoption. Recommendations for capitalizing on these opportunities include strategic partnerships with local healthcare providers to increase market penetration, investment in digital marketing to enhance brand visibility, and focusing on product innovation toward more portable and user-friendly designs. However, limitations such as high device costs, lack of trained personnel, and stringent regulatory hurdles pose challenges to market growth. Furthermore, concerns about device efficacy in varied clinical settings may affect adoption rates. Innovation in this domain can pivot around making devices more cost-effective, enhancing digital monitoring capabilities to track patient progress, and integrating AI for personalized therapy adjustments. Insight into the market's nature suggests it is fast-paced with moderate competition; companies should focus on R&D to stay ahead. Robust post-sale customer support and service could also be a differentiating factor, ensuring customer retention and satisfaction in a competitive landscape.

Understanding Market Dynamics in the High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
    • Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
    • Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
  • Market Restraints
    • Relatively High Cost Compared to Traditional Cannula
  • Market Opportunities
    • Technological Advancements in High-Flow Nasal Cannula
    • Favorable Regulatory Framework Supporting Commercialization
  • Market Challenges
    • Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula

Exploring Porter’s Five Forces for the High-flow Nasal Cannula Market

Porter’s Five Forces framework further strengthens the insights of the High-flow Nasal Cannula Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the High-flow Nasal Cannula Market

External macro-environmental factors deeply influence the performance of the High-flow Nasal Cannula Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the High-flow Nasal Cannula Market

The High-flow Nasal Cannula Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include SunMed, LLC, Flexicare (Group) Limited, ResMed, Inc., Armstrong Medical Limited, ICU Medical, Inc., Fairmont Medical Products Pty Ltd., Vapotherm, Inc., Masimo Corporation, Drägerwerk AG & Co. KGaA, BMC Medical Co., Ltd., Heka Medicals India Private Limited, Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Well Lead Medical Co., Ltd., Vyaire Medical, Inc., Narang Medical Limited, Teleflex Incorporated, MEKICS Co., Ltd., Great Group Medical Co., Ltd., Allied Medical Limited, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Synergy Intact Private Limited, nice Neotech Medical Systems Pvt. Ltd., and Sterimed Group.

Market Segmentation & Coverage

This research report categorizes the High-flow Nasal Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Component
    • Active Humidifier
    • Air Oxygen Blender
    • Heated Inspiratory Circuit
    • Nasal Cannula
  • Indication
    • Acute Heart Failure
    • Acute Respiratory Failure
    • Bronchiectasis
    • Carbon Monoxide Toxicity
    • Chronic Obstructive Pulmonary Disease
  • End User
    • Ambulatory Care Centers
    • Hospitals
    • Long-Term Care Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
5.1.2. Restraints
5.1.2.1. Relatively High Cost Compared to Traditional Cannula
5.1.3. Opportunities
5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
5.1.4. Challenges
5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
5.2. Market Segmentation Analysis
5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. High-flow Nasal Cannula Market, by Component
6.1. Introduction
6.2. Active Humidifier
6.3. Air Oxygen Blender
6.4. Heated Inspiratory Circuit
6.5. Nasal Cannula
7. High-flow Nasal Cannula Market, by Indication
7.1. Introduction
7.2. Acute Heart Failure
7.3. Acute Respiratory Failure
7.4. Bronchiectasis
7.5. Carbon Monoxide Toxicity
7.6. Chronic Obstructive Pulmonary Disease
8. High-flow Nasal Cannula Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Hospitals
8.4. Long-Term Care Centers
9. Americas High-flow Nasal Cannula Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific High-flow Nasal Cannula Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa High-flow Nasal Cannula Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness
List of Figures
FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 33. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 53. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 59. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 77. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 90. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the High-flow Nasal Cannula market, which are profiled in this report, include:
  • SunMed, LLC
  • Flexicare (Group) Limited
  • ResMed, Inc.
  • Armstrong Medical Limited
  • ICU Medical, Inc.
  • Fairmont Medical Products Pty Ltd.
  • Vapotherm, Inc.
  • Masimo Corporation
  • Drägerwerk AG & Co. KGaA
  • BMC Medical Co., Ltd.
  • Heka Medicals India Private Limited
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Corporation Limited
  • Well Lead Medical Co., Ltd.
  • Vyaire Medical, Inc.
  • Narang Medical Limited
  • Teleflex Incorporated
  • MEKICS Co., Ltd.
  • Great Group Medical Co., Ltd.
  • Allied Medical Limited
  • Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • Hamilton Medical AG
  • Synergy Intact Private Limited
  • nice Neotech Medical Systems Pvt. Ltd.
  • Sterimed Group

Methodology

Loading
LOADING...

Table Information